Home › Accelerated Phase Myeloid Leukemia
Accelerated Phase Myeloid Leukemia clinical trials recruiting in the U.S.
8 studies for Accelerated Phase Myeloid Leukemia are recruiting participants at sites across the United States.
Recently updated studies
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT03263572Personalized NK Cell Therapy in CBT
RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Nov 2, 2026 · NCT02727803Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
RecruitingPhase 1/2Healthy volunteers welcome
Up to age 50 · All sexes · Updated Oct 30, 2026 · NCT05322850Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 28, 2026 · NCT01137643A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT07020533Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 26, 2026 · NCT06802315MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Recruiting
Ages 0 to 25 · All sexes · Updated May 13, 2026 · NCT05794880From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.